News Sentiment

MBOT sentiment intelligence

Microbot Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 62 Constructive news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 1.78 Week of 12 Jun 2026
Weighted tone 62/100

Constructive news tone

Market reaction Positive news being faded

Constructive headlines are not being rewarded by price, which raises a rejection flag.

Primary event Market update

84/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-3.3% over one week, -3.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Negative

Microbot Medical Inc (MBOT) Risk Assessment: Volatility, Financial Risk & Investment Risk

Market Reaction

Positive news being faded

74/100 confidence

Constructive headlines are not being rewarded by price, which raises a rejection flag.

Primary event Market update 84/100 classification
One-week reaction -3.3% Price reacting lower
Trend fit Trend inactive -3.8% over four weeks
Fair value -2.4% Near fair-value range
Sentiment-trend disagreement

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 26
Neutral 18
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 14
Market source 7
Investing.com 6
TradingKey 4
TradingView 3
GuruFocus 2
The Robot Report 1
Minichart 1

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 4
Regulatory and legal 4
Analyst action 2
Capital return 1
Deals and strategy 1
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47
The Robot Report Direct company coverage

Microbot Medical to expand veteran access to robotic surgery with LIBERTY

Microbot Medical is partnering with Lovell Government Services to expand access to its LIBERTY Endovascular Robotic System for U.S. military veterans, active-duty service members, and Native American communities. This collaboration aims to get LIBERTY listed on federal contractin

Tone
Positive 75/100
Event
Market update
Published
18 Jun 2026 13:10
Source
The Robot Report
TradingKey Direct company coverage

Microbot Medical Inc (MBOT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Microbot Medical Inc (MBOT)'s dividend history and stock split information. It indicates that the company has not distributed any dividends over the past five years and has no recorded stock split events. The page also presents current stock p

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 19:10
Source
TradingKey
Market source Direct company coverage

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Microbot Medical Inc. has partnered with Lovell Government Services to expand access to its LIBERTY® Endovascular Robotic System for veteran and military patient populations across federal healthcare systems. This agreement will allow Microbot Medical to sell the LIBERTY System t

Tone
Positive 72/100
Event
Market update
Published
17 Jun 2026 09:10
Source
Market source
TradingKey Direct company coverage

Microbot Medical Inc (MBOT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Microbot Medical Inc (MBOT) currently holds an earnings forecast score of 8.00, placing it 163rd in the Biotechnology & Medical Research industry. Analysts have set an average price target of $8.75 for MBOT, with expectations of 100.00K in revenue and an EPS of -0.08 for the next

Tone
Positive 72/100
Event
Earnings
Published
17 Jun 2026 04:40
Source
TradingKey
TradingKey Direct company coverage

Microbot Medical Inc (MBOT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Microbot Medical Inc (MBOT), focusing on its stock price momentum, support and resistance levels, and key indicators. It notes that MBOT's stock price is currently trading between resistance at $2.11 and support at $1.59, suitable for

Tone
Negative 35/100
Event
Market update
Published
17 Jun 2026 04:40
Source
TradingKey
Minichart Direct company coverage

Microbot Medical Partners with Lovell to Expand LIBERTY® Endovascular Robotic System Access to Over 2,000 U.S. Government Healthcare Facilities

Microbot Medical Inc. has partnered with Lovell Government Services to significantly expand the reach of its LIBERTY® Endovascular Robotic System into over 2,000 U.S. government healthcare facilities, including the VHA, MHS, and IHS. This agreement, expected to activate in Q3 202

Tone
Positive 75/100
Event
Market update
Published
16 Jun 2026 12:39
Source
Minichart
Stock Titan Direct company coverage

Robotic vascular care for veterans: Microbot taps Lovell’s 2,000-site network

Microbot Medical has partnered with Lovell Government Services to provide its LIBERTY Endovascular Robotic System to over 2,000 U.S. government healthcare facilities, including those operated by the VA and DoD. This agreement positions LIBERTY for inclusion on Lovell's Federal Su

Tone
Positive 74/100
Event
Market update
Published
16 Jun 2026 12:39
Source
Stock Titan
TradingView Direct company coverage

Microbot Medical Inc Financial Disclosures & SEC Filings

This page provides access to Microbot Medical Inc.'s financial disclosures and SEC filings, including quarterly and annual reports (10-Q and 10-K). It details the company's financial performance, such as net losses and capital raises, and highlights key operational milestones lik

Tone
Positive 60/100
Event
Market update
Published
13 Jun 2026 01:09
Source
TradingView
Investing.com Australia Direct company coverage

Microbot Medical stock rises on Michigan health system deal By Investing.com

Microbot Medical Inc. shares rose after the company announced its LIBERTY Endovascular Robotic System secured its first Michigan health system customer, marking its first in the Midwest. This expansion follows a recent addition in North Carolina, highlighting growing demand for a

Tone
Positive 81/100
Event
Deals and strategy
Published
09 Jun 2026 13:39
Source
Investing.com Australia
Market source Direct company coverage

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System

Microbot Medical Inc. announced that a major health system in Michigan has become the first in the state and Midwest to adopt its LIBERTY® Endovascular Robotic System. This marks Microbot Medical's continued expansion across the U.S., following a recent adoption in North Carolina

Tone
Positive 92/100
Event
Market update
Published
09 Jun 2026 12:39
Source
Market source
Stock Titan Direct company coverage

One of Michigan’s largest health systems adopts FDA-cleared vascular robot

Microbot Medical Inc. announced that a major Michigan healthcare system has adopted its FDA-cleared LIBERTY Endovascular Robotic System, marking its first customer in Michigan and the broader Midwest. This expands the company's market presence following its first North Carolina c

Tone
Positive 71/100
Event
Market update
Published
09 Jun 2026 12:39
Source
Stock Titan
Stock Titan Direct company coverage

Microbot Medical (NASDAQ: MBOT) adds major Michigan LIBERTY customer

Microbot Medical Inc. (NASDAQ: MBOT) announced that its LIBERTY Endovascular Robotic System has been adopted by a major healthcare system in Michigan, marking its first Midwest-based customer. This follows a previous adoption in North Carolina, indicating expanding regional prese

Tone
Positive 71/100
Event
Market update
Published
09 Jun 2026 12:39
Source
Stock Titan
Investing.com Direct company coverage

Microbot Medical secures Michigan healthcare system customer

Microbot Medical announced that its LIBERTY Endovascular Robotic System has been adopted by a large healthcare system in Michigan, marking its first deployment in Michigan and the broader Midwest region. This is the company's second healthcare system customer in the U.S., followi

Tone
Positive 66/100
Event
Market update
Published
09 Jun 2026 12:39
Source
Investing.com
Investing.com Direct company coverage

Lucid Capital Markets initiates Microbot Medical stock with buy rating

Lucid Capital Markets has initiated coverage on Microbot Medical (NASDAQ:MBOT) with a "buy" rating and a $4.00 price target, suggesting a nearly 100% upside from its current trading price of $2.01. The firm highlights Microbot's Liberty system as a novel approach in the largely u

Tone
Positive 72/100
Event
Analyst action
Published
03 Jun 2026 16:10
Source
Investing.com
Sahm Direct company coverage

Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System

Microbot Medical Inc. (Nasdaq: MBOT) announced that it has secured its first North Carolina-based customer for its LIBERTY® Endovascular Robotic System, expanding its geographic reach in the Southeast, Mid-Atlantic, and Northeast U.S. This marks a leading academic center as the f

Tone
Positive 92/100
Event
Market update
Published
02 Jun 2026 17:39
Source
Sahm
Intellectia AI Direct company coverage

Microbot Medical Secures First Customer in North Carolina

Microbot Medical has secured its first customer in North Carolina for its LIBERTY® Endovascular Robotic System, marking a significant step in the company's market expansion in the Southeast and Mid-Atlantic regions. This new customer operates a multi-hospital network, validating

Tone
Positive 72/100
Event
Market update
Published
02 Jun 2026 15:09
Source
Intellectia AI
TradingView Direct company coverage

Microbot Medical secures first North Carolina healthcare system for LIBERTY endovascular robot

Microbot Medical has secured its first North Carolina healthcare system customer for the LIBERTY Endovascular Robotic System. This new account is a multi-hospital academic network, marking a significant expansion of the company's geographic reach and reflecting accelerating new-a

Tone
Positive 74/100
Event
Market update
Published
02 Jun 2026 12:39
Source
TradingView
Stock Titan Direct company coverage

Microbot Medical (MBOT) lands first North Carolina health system for LIBERTY

Microbot Medical Inc. announced that it has secured its first North Carolina-based customer, a leading academic center with a multi-hospital network, for its LIBERTY® Endovascular Robotic System. This expands LIBERTY's geographic presence into the broader northeast and South-Atla

Tone
Positive 70/100
Event
Market update
Published
02 Jun 2026 12:39
Source
Stock Titan
Simply Wall Street Direct company coverage

We're Hopeful That Microbot Medical (NASDAQ:MBOT) Will Use Its Cash Wisely

Microbot Medical (NASDAQ:MBOT) has a strong cash runway of 4.7 years based on its US$73 million cash reserves and an annual cash burn of US$15 million. While its cash burn rate increased by 65% over the last year, the company's substantial cash reserves and relatively small marke

Tone
Positive 61/100
Event
Balance sheet
Published
30 May 2026 14:39
Source
Simply Wall Street
Market source Direct company coverage

Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System

Microbot Medical Inc. (Nasdaq: MBOT) announced that Israel has granted marketing clearance for its LIBERTY® Endovascular Robotic System, making it the first international approval outside the U.S. This approval allows Microbot to commercialize the system in Israel and obtain a Fr

Tone
Positive 90/100
Event
Regulatory and legal
Published
28 May 2026 06:10
Source
Market source
Investing.com Direct company coverage

Microbot Medical earnings beat by $0.03, revenue fell short of estimates

Microbot Medical (NASDAQ: MBOT) reported first-quarter EPS of $-0.050, which beat analyst estimates by $0.03. However, the company's revenue for the quarter came in at $105K, falling short of the consensus estimate of $300K. The stock has seen a decline of -24.900% in the last th

Tone
Neutral 50/100
Event
Earnings
Published
27 May 2026 04:41
Source
Investing.com
Investing.com Direct company coverage

Microbot Medical receives Israel approval for robotic system

Microbot Medical Inc. received marketing clearance from Israel's Ministry of Health for its LIBERTY Endovascular Robotic System, marking Israel as the second country to approve the device. This approval allows Microbot Medical to commercialize the system in Israel and obtain a Fr

Tone
Positive 65/100
Event
Regulatory and legal
Published
26 May 2026 23:41
Source
Investing.com
Investing.com Nigeria Direct company coverage

Microbot Medical receives Israel approval for robotic system By Investing.com

Microbot Medical Inc. has received marketing clearance from Israel's Ministry of Health for its LIBERTY Endovascular Robotic System, making Israel the first country outside the U.S. to approve the device. This approval is a significant regulatory milestone for the company, suppor

Tone
Positive 72/100
Event
Regulatory and legal
Published
26 May 2026 13:41
Source
Investing.com Nigeria
Stock Titan Direct company coverage

[8-K] Microbot Medical Inc. Reports Material Event

Microbot Medical Inc. announced that its LIBERTY® Endovascular Robotic System has received regulatory approval from Israel’s Ministry of Health AMAR Division. This approval allows the company to market and commercialize LIBERTY in Israel and obtain a Free Sale Certificate for oth

Tone
Positive 71/100
Event
Regulatory and legal
Published
26 May 2026 12:10
Source
Stock Titan